These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Study dispels assumptions about adverse drug events. Rollins G Rep Med Guidel Outcomes Res; 2001 Aug; 12(17):1-2, 5. PubMed ID: 12296363 [No Abstract] [Full Text] [Related]
44. Intensive monitoring of new drugs based on first prescription signals from pharmacists: a pilot study. van Grootheest AC; Groote JK; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2003 Sep; 12(6):475-81. PubMed ID: 14513661 [TBL] [Abstract][Full Text] [Related]
45. An overview of spontaneous reporting of adverse drug reactions (ARDs) in Zimbabwe. Ball D Cent Afr J Med; 2000 Jan; 46(1):23-4. PubMed ID: 14674204 [No Abstract] [Full Text] [Related]
46. A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. McKenzie MW; Stewart RB; Weiss CF; Cluff LE Am J Hosp Pharm; 1973 Oct; 30(10):898-903. PubMed ID: 4747029 [No Abstract] [Full Text] [Related]
47. Recent news about drug risks: application to Canadians. Hogan V; Turner C CMAJ; 1998 Oct; 159(7):845-6; 849-50. PubMed ID: 9805036 [No Abstract] [Full Text] [Related]
48. Bring back the mustard plaster. Handler S Minn Med; 1971 Dec; 54(12):973-9. PubMed ID: 5122039 [No Abstract] [Full Text] [Related]
49. [Iatrogenic disease in old age]. Hitzenberger G Aktuelle Gerontol; 1982 Jul; 12(4):139-41. PubMed ID: 6126137 [No Abstract] [Full Text] [Related]
50. Adverse drug reactions in a department of pediatric surgery. Farrokhi S; Nahvi H; Pourpak Z; Moin M; Majdinasab P; Gholami K; Kazemnejad A J Trop Pediatr; 2006 Feb; 52(1):72-3. PubMed ID: 15980025 [No Abstract] [Full Text] [Related]
51. Improving how we evaluate the toxicity of approved drugs. Reidenberg MM Clin Pharmacol Ther; 2006 Jul; 80(1):1-6. PubMed ID: 16815311 [No Abstract] [Full Text] [Related]
52. Adverse drug events among elderly outpatients are common and preventable. Rollins G Rep Med Guidel Outcomes Res; 2003 Apr; 14(7):1, 6-7. PubMed ID: 12848148 [No Abstract] [Full Text] [Related]
53. The perils of prescribing. Parsons J Aust Fam Physician; 2002 Feb; 31(2):119. PubMed ID: 11917818 [No Abstract] [Full Text] [Related]
54. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Blenkinsopp A; Wilkie P; Wang M; Routledge PA Br J Clin Pharmacol; 2007 Feb; 63(2):148-56. PubMed ID: 17274788 [TBL] [Abstract][Full Text] [Related]
55. Role of a pharmacist in improving rational drug therapy as part of the patient care team. Smith WE Ann Pharmacother; 2007 Feb; 41(2):330-5. PubMed ID: 17299008 [TBL] [Abstract][Full Text] [Related]
56. Iatrogenesis: 'the hidden and general dangers'. Ferguson RP Hosp Pract (Off Ed); 1989 Jan; 24(1A):89-94. PubMed ID: 2492294 [No Abstract] [Full Text] [Related]
57. Study shows big picture on adverse drug effects. Morrissey J Mod Healthc; 1995 Jul; 25(30):76, 78. PubMed ID: 10144292 [No Abstract] [Full Text] [Related]
58. [Criteria of imputability in accidents of drug-induced origin]. Bégaud B Rev Prat; 2000 Oct; 50(16):1803-6. PubMed ID: 11103134 [No Abstract] [Full Text] [Related]
59. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia. Aziz Z; Siang TC; Badarudin NS Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117 [TBL] [Abstract][Full Text] [Related]
60. Connecticut Prescription Monitoring and Reporting System (CPMRS). How prescribers and pharmacists can help reduce prescription drug misuse and abuse. Conn Med; 2008 Aug; 72(7):439-40. PubMed ID: 18763674 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]